Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact
- PMID: 22189537
- DOI: 10.1097/INF.0b013e3182458289
Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact
Abstract
A total of 105 low-birth-weight children presenting for first vaccination were randomized to receive bacillus Calmette-Guérin (BCG) immediately or later (current practice). The mortality rate ratio for BCG was 0.17 (95% CI = 0.02-1.35) within 3 days of enrollment, 0.28 (0.06-1.37) in the first month, and 0.27 (0.07-0.98) after 2 months of age. The mortality rate ratio was 0.41 (0.14-1.18) (P = 0.098) in infancy. Administration of BCG vaccine at first contact may contribute to lower mortality.
Trial registration: ClinicalTrials.gov NCT00146302.
Comment in
-
Commentary: BCG vaccination halves neonatal mortality.Pediatr Infect Dis J. 2012 Mar;31(3):308-9. doi: 10.1097/INF.0b013e3182465be8. Pediatr Infect Dis J. 2012. PMID: 22330168 No abstract available.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
